prx-119
Generic: Long Acting (LA) DNase I·Code: PRX-119
prx-119: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | Preclinical |
Get deeper analysis on prx-119
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis